"have nothing to do with it anyway." It does. It is hypocritical to criticise others, if you have done much much worse. If you are going to criticise someone else, it is only fair to accept criticism of your own calls. Previously you had a sentiment of "BUY" at 1.8c (72819059) then again at 0.3c (72819059), your disclosure/sentiment remained unchanged. Furthermore, if you are going to perform cross stock comparisons, in an attempt to see which stock performs better, why not make it realistic and address the confounding factor of short term volatility due to catalysts? If you look at when you first said ASX:CHK could go nuclear (2021), and compare that stock to ASX:MAY, the long term trend for CHK is down, the long term trend since 2021 for ASX:MAY is up.
It is quite clear that ASX:MAY has retained some value from all the catalysts that have emerged thus far. ASX:CHK on the other hand keeps decreasing.
Figure 1: CHK.ax compared to MAY.ax using yahoofinance closing prices via python + matplotlib.
- Forums
- ASX - By Stock
- MAY
- MOVE your SUPER-TANKER out of my DEEP-WATER PORT
MOVE your SUPER-TANKER out of my DEEP-WATER PORT, page-393
-
- There are more pages in this discussion • 725 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MAY (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $107.8M |
Open | High | Low | Value | Volume |
3.2¢ | 3.2¢ | 3.0¢ | $24.13K | 779.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1332211 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 1037924 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 1332211 | 0.030 |
16 | 1508439 | 0.029 |
9 | 2932858 | 0.028 |
6 | 1364740 | 0.027 |
3 | 488499 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 1037924 | 4 |
0.033 | 581594 | 8 |
0.034 | 1028000 | 3 |
0.035 | 1040266 | 2 |
0.037 | 324062 | 4 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
MAY (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online